SPC Financial Inc’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $605K | Buy |
7,294
+34
| +0.5% | +$2.82K | 0.05% | 158 |
|
|
2025
Q1 | $589K | Buy |
7,260
+2,479
| +52% | +$201K | 0.05% | 157 |
|
|
2024
Q4 | $431K | Sell |
4,781
-1,730
| -27% | -$156K | 0.04% | 182 |
|
|
2024
Q3 | $643K | Sell |
6,511
-161
| -2% | -$15.9K | 0.06% | 144 |
|
|
2024
Q2 | $619K | Buy |
6,672
+72
| +1% | +$6.68K | 0.06% | 130 |
|
|
2024
Q1 | $626K | Buy |
6,600
+3,838
| +139% | +$364K | 0.06% | 132 |
|
|
2023
Q4 | $247K | Sell |
2,762
-4,848
| -64% | -$433K | 0.03% | 199 |
|
|
2023
Q3 | $556K | Buy |
7,610
+138
| +2% | +$10.1K | 0.06% | 133 |
|
|
2023
Q2 | $622K | Buy |
7,472
+325
| +5% | +$27K | 0.07% | 121 |
|
|
2023
Q1 | $545K | Buy |
+7,147
| New | +$545K | 0.06% | 126 |
|
|
2022
Q4 | – | Sell |
-7,881
| Closed | -$625K | – | 212 |
|
|
2022
Q3 | $625K | Sell |
7,881
-385
| -5% | -$30.5K | 0.08% | 109 |
|
|
2022
Q2 | $614K | Sell |
8,266
-1,942
| -19% | -$144K | 0.08% | 112 |
|
|
2022
Q1 | $917K | Buy |
10,208
+8,394
| +463% | +$754K | 0.11% | 80 |
|
|
2021
Q4 | $203K | Sell |
1,814
-7,846
| -81% | -$878K | 0.02% | 186 |
|
|
2021
Q3 | $1.21M | Buy |
9,660
+530
| +6% | +$66.6K | 0.15% | 68 |
|
|
2021
Q2 | $1.24M | Buy |
9,130
+1,524
| +20% | +$206K | 0.15% | 66 |
|
|
2021
Q1 | $1.03M | Sell |
7,606
-7,806
| -51% | -$1.06M | 0.14% | 67 |
|
|
2020
Q4 | $2.17M | Buy |
+15,412
| New | +$2.17M | 0.31% | 52 |
|